Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation

Fig. 2

Differences in the serum protein levels may be associated with the frequency of post-HCT acute graft versus host disease (GVHD). The serum protein profile was analyzed between a patient with grade 3 acute GVHD (a 65-year-old woman with AML) and a patient without acute GVHD (a 61-year-old woman with AML) on day + 14 after HCT

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us